Marginal structural models for the estimation of the risk of Diabetes Mellitus in the presence of elevated depressive symptoms and antidepressant medication use in the Women’s Health Initiative observational and clinical trial cohorts

BMC Endocrine Disorders

Raji Balasubramanian²  Deidre Sepavich¹  Martha Zorn²  Penelope Pekow²  Yunsheng Ma¹  Brian Whitcomb²  Xiangdong Gu²  Christine Frisard¹ 

[1] Division of Preventive and Behavioral Medicine, Department of Medicine, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester 01655, MA, USA;Division of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, 715 North Pleasant Street, Amherst 01003, MA, USA

关键词: Propensity score;    Marginal structural models;    Type 2 diabetes;    Depression;    Antidepressant medication;   

Others  :  1228284
DOI  :  10.1186/s12902-015-0049-7

 received in 2015-04-07, accepted in 2015-09-18,  发布年份 2015

【 摘 要 】

Background

We evaluate the combined effect of the presence of elevated depressive symptoms and antidepressant medication use with respect to risk of type 2 diabetes among approximately 120,000 women enrolled in the Women’s Health Initiative (WHI), and compare several different statistical models appropriate for causal inference in non-randomized settings.

Methods

Data were analyzed for 52,326 women in the Women’s Health Initiative Clinical Trials (CT) Cohort and 68,169 women in the Observational Study (OS) Cohort after exclusions. We included follow-up to 2005, resulting in a median duration of 7.6 years of follow up after enrollment. Results from three multivariable Cox models were compared to those from marginal structural models that included time varying measures of antidepressant medication use, presence of elevated depressive symptoms and BMI, while adjusting for potential confounders including age, ethnicity, education, minutes of recreational physical activity per week, total energy intake, hormone therapy use, family history of diabetes and smoking status.

Results

Our results are consistent with previous studies examining the relationship of antidepressant medication use and risk of type 2 diabetes. All models showed a significant increase in diabetes risk for those taking antidepressants. The Cox Proportional Hazards models using baseline covariates showed the lowest increase in risk , with hazard ratios of 1.19 (95 % CI 1.06 – 1.35) and 1.14 (95 % CI 1.01 – 1.30) in the OS and CT, respectively. Hazard ratios from marginal structural models comparing antidepressant users to non-users were 1.35 (95 % CI 1.21 – 1.51) and 1.27 (95 % CI 1.13 – 1.43) in the WHI OS and CT, respectively – however, differences among estimates from traditional Cox models and marginal structural models were not statistically significant in both cohorts. One explanation suggests that time-dependent confounding was not a substantial factor in these data, however other explanations exist. Unadjusted Cox Proportional Hazards models showed that women with elevated depressive symptoms had a significant increase in diabetes risk that remained after adjustment for confounders. However, this association missed the threshold for statistical significance in propensity score adjusted and marginal structural models.

Conclusions

Results from the multiple approaches provide further evidence of an increase in risk of type 2 diabetes for those on antidepressants.

【 授权许可】

   
2015 Frisard et al.

【 图 表 】

Figure 2.

【 参考文献 】

• [1]Kim CK, McGorray SP, Bartholomew BA, Marsh M, Dicken T, Wassertheil-Smoller S et al.. Depressive symptoms and heart rate variability in postmenopausal women. Arch Intern Med. 2005; 165(11):1239-44.
• [2]Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53.
• [3]Brown LC, Majumdar SR, Johnson JA. Type of antidepressant therapy and risk of type 2 diabetes in people with depression. Diabetes Res Clin Pract. 2008; 79(1):61-7.
• [4]Rubin RR, Ma Y, Marrero DG, Peyrot M, Barrett-Connor EL, Kahn SE et al.. Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care. 2008; 31(3):420-6.
• [5]Andersohn F, Schade R, Suissa S, Garbe E. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry. 2009; 166(5):591-8.
• [6]Campayo A, de Jonge P, Roy JF, Saz P, de la Camara C, Quintanilla MA et al.. Depressive disorder and incident diabetes mellitus: the effect of characteristics of depression. Am J Psychiatry. 2010; 167(5):580-8.
• [7]Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009; 66(8):848-56.
• [8]The Medicated Americans: Antidepressant Prescriptions on the Rise July 15, 2013. http://www.sciam.com/article.cfm?id=the-medicated-americans.
• [9]Ma Y, Balasubramanian R, Pagoto SL, Schneider KL, Culver AL, Olendzki B et al.. Elevated depressive symptoms, antidepressant use, and diabetes in a large multiethnic national sample of postmenopausal women. Diabetes Care. 2011; 34(11):2390-2.
• [10]Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology. 2000; 11(5):561-70.
• [11]Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000; 11(5):550-60.
• [12]Robins JM. Causal inference from complex longitudinal data. In: Berkane M, editor. Latent Variable Modeling and Applications to Causality. Lecture Notes in Statistics (120). New York, NY: Springer Verlag; 1997. p. 69–117.
• [13]Geoffroy MC, Li L, Power C. Depressive symptoms and body mass index: co-morbidity and direction of association in a British birth cohort followed over 50 years. Psychol Med.44(12):2641-52. doi: 10.1017/S0033291714000142.
• [14]Chen AB, Li L, Cronin A, Schrag D. Comparative Effectiveness of Intensity-Modulated Versus 3D Conformal Radiation Therapy Among Medicare Patients with Stage III Lung Cancer. J Thorac Oncol. 2014.
• [15]Farber HW, Miller DP, McGoon MD, Frost AE, Benton WW, Benza RL. Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance. J Heart Lung Transplant. 2014.
• [16]Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials. 1998;19(1):61-109.
• [17]Ritenbaugh C, Patterson RE, Chlebowski RT, Caan B, Fels-Tinker L, Howard B et al.. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Ann Epidemiol. 2003; 13(9 Suppl):S87-97.
• [18]Stefanick ML, Cochrane BB, Hsia J, Barad DH, Liu JH, Johnson SR. The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants. Ann Epidemiol. 2003; 13(9 Suppl):S78-86.
• [19]Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M. The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol. 2003; 13(9 Suppl):S107-21.
• [20]Margolis KL, Lihong Q, Brzyski R, Bonds DE, Howard BV, Kempainen S et al.. Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials. 2008; 5(3):240-7.
• [21]Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994; 10(2):77-84.
• [22]Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983; 70(1):41-55.
• [23]Harlow S, Linet M. Reviews and commentary: Agreement between questionnaire data and medical records: the evidence for accuracy of recall. American journal of epidemiology. 1989; 129(2):233-48.
• [24]Pearl J. Understanding propensity scores. Causality: Models, Reasoning, and Inference. 2nd ed. New York: Cambridge University Press; 2009.
• [25]Pearl J. Causality: Models, Reasoning, and Inference. New York: Cambridge University Press; 2000.
• [26]Marcus A, Crane L. Smoking behavior among U.S. Latinos: an emerging challenge for public health. American journal of public health. 1985; 75:169-72.
• [27]Pan A, Sun Q, Okereke OI, Rexrode KM, Rubin RR, Lucas M et al.. Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults. Diabetologia. 2012; 55(1):63-72.
• [28]Fruchter R, Boyce J, Hunt M. Missed opportunities for early diagnosis of cancer of the cervix. American journal of public health. 1980; 70:418-20.